{"id":5674,"date":"2020-01-23T11:55:20","date_gmt":"2020-01-23T11:55:20","guid":{"rendered":"http:\/\/imas12.es\/en\/?p=5674"},"modified":"2020-01-23T11:55:20","modified_gmt":"2020-01-23T11:55:20","slug":"investigadores-del-instituto-de-investigacion-i12-colaboran-en-el-descubrimiento-de-una-conexion-entre-los-gliomas-y-las-enfermedades-neurodegenerativas","status":"publish","type":"post","link":"https:\/\/imas12.es\/en\/investigadores-del-instituto-de-investigacion-i12-colaboran-en-el-descubrimiento-de-una-conexion-entre-los-gliomas-y-las-enfermedades-neurodegenerativas\/","title":{"rendered":"Investigadores del Instituto de Investigaci\u00f3n i+12 colaboran en el descubrimiento de una conexi\u00f3n entre los gliomas y las enfermedades neurodegenerativas."},"content":{"rendered":"<p>Investigadores de la Unidad Funcional de Investigaci\u00f3n de Enfermedades Cr\u00f3nicas del Instituto de Salud Carlos III (ISCIII), en colaboraci\u00f3n con investigadores de la Asociaci\u00f3n Espa\u00f1ola de Lucha contra el C\u00e1ncer (AECC), del CiberNED y del Centro de Biolog\u00eda Molecular del CSIC y con m\u00e9dicos del Hospital 12 de Octubre, integrados en el Instituto de Investigaci\u00f3n Sanitaria i+12, descubren que la<strong> prote\u00edna tau <\/strong>tambi\u00e9n est\u00e1 presente en los gliomas.<\/p>\n<p>El estudio, publicado en <a href=\"https:\/\/stm.sciencemag.org\/\" target=\"_blank\" rel=\"noopener\"><em><span style=\"text-decoration: none\">Science Translational Medicine<\/span><\/em><\/a>, demuestra que la prote\u00edna tau, que tradicionalmente se ha relacionado con diversas patolog\u00edas degenerativas en el cerebro, est\u00e1 presente en las c\u00e9lulas de los gliomas.<\/p>\n<p>Fuente: <strong>Diario M\u00e9dico<\/strong><\/p>\n<p><a href=\"https:\/\/www.diariomedico.com\/especialidades\/neurologia\/descubren-que-la-proteina-tau-tambien-esta-presente-en-los-gliomas.html\" target=\"_blank\" rel=\"noopener\">M\u00e1s Informaci\u00f3n<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investigadores de la Unidad Funcional de Investigaci\u00f3n de Enfermedades Cr\u00f3nicas del Instituto de Salud Carlos III (ISCIII), en colaboraci\u00f3n con investigadores de la Asociaci\u00f3n Espa\u00f1ola de Lucha contra el C\u00e1ncer (AECC), del CiberNED y del Centro de Biolog\u00eda Molecular del&#8230;<\/p>\n","protected":false},"author":8,"featured_media":5675,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5674","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria"],"_links":{"self":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/posts\/5674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/comments?post=5674"}],"version-history":[{"count":1,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/posts\/5674\/revisions"}],"predecessor-version":[{"id":5676,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/posts\/5674\/revisions\/5676"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/media\/5675"}],"wp:attachment":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/media?parent=5674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/categories?post=5674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/tags?post=5674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}